{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:51Z","timestamp":1787030571434,"version":"build-2736575974"},"reference-count":46,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15334","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T11:35:24Z","timestamp":1760441724000},"page":"1-10","source":"Crossref","is-referenced-by-count":3,"title":["Bortezomib overcomes TRAIL resistance in Burkitt's lymphoma by enhancing apoptosis via reactive oxygen species\u2011mediated DR5 upregulation and MAPK pathway activation"],"prefix":"10.3892","volume":"30","author":[{"given":"Jiajie","family":"Chen","sequence":"first","affiliation":[{"name":"School of Basic Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"You","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Pu","sequence":"additional","affiliation":[{"name":"School of Laboratory Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Bai","sequence":"additional","affiliation":[{"name":"School of Bioscience and Technology, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Li","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"key20251111103947_b1-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11912-020-0898-8","article-title":"Burkitt and burkitt-like lymphomas: A systematic review","volume":"22","author":"Saleh","year":"2020","journal-title":"Curr Oncol Rep"},{"key":"key20251111103947_b2-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"103193","DOI":"10.1016\/j.eclinm.2025.103193","article-title":"Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: Population-based estimates from GLOBOCAN 2022","volume":"83","author":"Sun","year":"2025","journal-title":"EClinicalMedicine"},{"key":"key20251111103947_b3-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"1059914","DOI":"10.3389\/fonc.2023.1059914","article-title":"The epidemiological patterns of non-Hodgkin lymphoma: Global estimates of disease burden, risk factors, and temporal trends","volume":"13","author":"Chu","year":"2023","journal-title":"Front Oncol"},{"key":"key20251111103947_b4-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"key":"key20251111103947_b5-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.omto.2023.03.002","article-title":"Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells","volume":"29","author":"Holmes","year":"2023","journal-title":"Mol Ther Oncolytics"},{"key":"key20251111103947_b6-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1182\/blood-2014-06-538504","article-title":"How I treat Burkitt lymphoma in adults","volume":"124","author":"Jacobson","year":"2014","journal-title":"Blood"},{"key":"key20251111103947_b7-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.biopha.2017.12.082","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies","volume":"98","author":"Naimi","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"key20251111103947_b8-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/cdd.2014.81","article-title":"Getting TRAIL back on track for cancer therapy","volume":"21","author":"Lemke","year":"2014","journal-title":"Cell Death Differ"},{"key":"key20251111103947_b9-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1182\/blood-2007-08-110445","article-title":"Bortezomib blocks bax degradation in malignant B cells during treatment with TRAIL","volume":"111","author":"Liu","year":"2008","journal-title":"Blood"},{"key":"key20251111103947_b10-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/biom11040572","article-title":"Overcoming TRAIL resistance for glioblastoma treatment","volume":"11","author":"Deng","year":"2021","journal-title":"Biomolecules"},{"key":"key20251111103947_b11-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/pharmaceutics13071062","article-title":"Behind the adaptive and resistance mechanisms of cancer stem cells to TRAIL","volume":"13","author":"Quiroz-Reyes","year":"2021","journal-title":"Pharmaceutics"},{"key":"key20251111103947_b12-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"RCR5154","DOI":"10.59761\/RCR5154","article-title":"Cytokine TRAIL death receptor agonists: Design strategies and clinical prospects","volume":"94","author":"Yagolovich","year":"2025","journal-title":"Russian Chemical Reviews"},{"key":"key20251111103947_b13-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.3390\/cells11233717","article-title":"Targeting TRAIL death receptors in triple-negative breast cancers: Challenges and strategies for cancer therapy","volume":"11","author":"Kundu","year":"2022","journal-title":"Cells"},{"key":"key20251111103947_b14-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drup.2008.02.001","article-title":"TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them","volume":"11","author":"Thorburn","year":"2008","journal-title":"Drug Resist Updat"},{"key":"key20251111103947_b15-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1038\/s41388-021-01697-6","article-title":"Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization","volume":"40","author":"Cingoz","year":"2021","journal-title":"Oncogene"},{"key":"key20251111103947_b16-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40268-019-0269-9","article-title":"Bortezomib for the treatment of hematologic malignancies: 15 years later","volume":"19","author":"Robak","year":"2019","journal-title":"Drugs R D"},{"key":"key20251111103947_b17-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.7150\/ijms.34398","article-title":"Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL","volume":"16","author":"Bui","year":"2019","journal-title":"Int J Med Sci"},{"key":"key20251111103947_b18-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12885-018-4352-3","article-title":"The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells","volume":"18","author":"Ryu","year":"2018","journal-title":"BMC Cancer"},{"key":"key20251111103947_b19-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s10495-006-8048-9","article-title":"The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells","volume":"11","author":"Kabore","year":"2006","journal-title":"Apoptosis"},{"key":"key20251111103947_b20-ol-30-6-15334","first-page":"413","article-title":"Sensitivity of tumor necrosis factor-related apoptosis-inducing ligands in B lymphoma cell lines and mechanisms of apoptosis induction","volume":"11","author":"Qin","year":"2016","journal-title":"J Chengdu Med Coll"},{"key":"key20251111103947_b21-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"107916","DOI":"10.1016\/j.pharmthera.2021.107916","article-title":"The mechanism of action of N-acetylcysteine (NAC): The emerging role of H(2)S and sulfane sulfur species","volume":"228","author":"Pedre","year":"2021","journal-title":"Pharmacol Ther"},{"key":"key20251111103947_b22-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00726-017-2395-4","article-title":"RGD and NGR modified TRAIL protein exhibited potent anti-metastasis effects on TRAIL-insensitive cancer cells in vitro and in vivo","volume":"49","author":"Wang","year":"2017","journal-title":"Amino Acids"},{"key":"key20251111103947_b23-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"key20251111103947_b24-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1023\/A:1009616228304","article-title":"Role of reactive oxygen species (ROS) in apoptosis induction","volume":"5","author":"Simon","year":"2000","journal-title":"Apoptosis"},{"key":"key20251111103947_b25-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"112388","DOI":"10.1016\/j.fct.2021.112388","article-title":"Mitophagy and apoptosis mediated by ROS participate in AlCl(3)-induced MC3T3-E1 cell dysfunction","volume":"155","author":"Liu","year":"2021","journal-title":"Food Chem Toxicol"},{"key":"key20251111103947_b26-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1038\/s41388-019-0693-x","article-title":"RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer","volume":"38","author":"Kim","year":"2019","journal-title":"Oncogene"},{"key":"key20251111103947_b27-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"45495","DOI":"10.1074\/jbc.M406933200","article-title":"CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"key20251111103947_b28-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3892\/ijmm.2022.5110","article-title":"Myricetin induces apoptosis through the MAPK pathway and regulates JNK-mediated autophagy in SK-BR-3 cells","volume":"49","author":"Han","year":"2022","journal-title":"Int J Mol Med"},{"key":"key20251111103947_b29-ol-30-6-15334","first-page":"12","article-title":"Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells","volume":"7","author":"De Wilt","year":"2024","journal-title":"Cancer Drug Resist"},{"key":"key20251111103947_b30-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3892\/or.2022.8423","article-title":"The role of interaction between autophagy and apoptosis in tumorigenesis (Review)","volume":"48","author":"Xi","year":"2022","journal-title":"Oncol Rep"},{"key":"key20251111103947_b31-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.fct.2019.01.023","article-title":"Diallyl disulfide (DADS) boosts TRAIL-Mediated apoptosis in colorectal cancer cells by inhibiting Bcl-2","volume":"125","author":"Kim","year":"2019","journal-title":"Food Chem Toxicol"},{"key":"key20251111103947_b32-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1182\/blood-2014-03-560284","article-title":"Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma","volume":"123","author":"Fresquet","year":"2014","journal-title":"Blood"},{"key":"key20251111103947_b33-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.bbrc.2005.04.161","article-title":"Unknotting the roles of Bcl-2 and Bcl-xL in cell death","volume":"333","author":"Kim","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"key20251111103947_b34-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1038\/s41467-021-27200-z","article-title":"How to build a ribosome from RNA fragments in Chlamydomonas mitochondria","volume":"12","author":"Waltz","year":"2021","journal-title":"Nat Commun"},{"key":"key20251111103947_b35-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1182\/blood-2008-05-157974","article-title":"A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma","volume":"112","author":"Lan","year":"2008","journal-title":"Blood"},{"key":"key20251111103947_b36-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.taap.2018.05.022","article-title":"TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells","volume":"352","author":"Jin","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"key20251111103947_b37-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.3390\/cancers14133043","article-title":"AF8c, a multi-kinase inhibitor induces apoptosis by activating DR5\/Nrf2 via ROS in colorectal cancer cells","volume":"14","author":"Jeong","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20251111103947_b38-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.kint.2024.10.026","article-title":"TRAIL induces podocyte PANoptosis via death receptor 5 in diabetic kidney disease","volume":"107","author":"Lv","year":"2024","journal-title":"Kidney Int"},{"key":"key20251111103947_b39-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.3390\/cancers16173092","article-title":"Apoptosis of pancreatic cancer cells after co-treatment with eugenol and tumor necrosis factor-related apoptosis-inducing ligand","volume":"16","author":"Kim","year":"2024","journal-title":"Cancers (Basel)"},{"key":"key20251111103947_b40-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"116936","DOI":"10.1016\/j.ecoenv.2024.116936","article-title":"The ototoxicity of chlorinated paraffins via inducing apoptosis, oxidative stress and endoplasmic reticulum stress in cochlea hair cells","volume":"284","author":"Liao","year":"2024","journal-title":"Ecotoxicol Environ Saf"},{"key":"key20251111103947_b41-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.3390\/nu16183085","article-title":"Effects of melatonin and 3,5,3\u2032-Triiodothyronine on the development of rat granulosa cells","volume":"16","author":"Wu","year":"2024","journal-title":"Nutrients"},{"key":"key20251111103947_b42-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"14951","DOI":"10.1002\/jcp.28334","article-title":"RAS\/MAPK signaling functions in oxidative stress, DNA damage response and cancer progression","volume":"234","author":"Rezatabar","year":"2019","journal-title":"J Cell Physiol"},{"key":"key20251111103947_b43-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0065-230X(08)60765-4","article-title":"Signal transduction through MAP kinase cascades","volume":"74","author":"Lewis","year":"1998","journal-title":"Adv Cancer Res"},{"key":"key20251111103947_b44-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"1480562","DOI":"10.3389\/fphar.2024.1480562","article-title":"Network pharmacology, experimental validation and pharmacokinetics integrated strategy to reveal pharmacological mechanism of goutengsan on methamphetamine dependence","volume":"15","author":"Li","year":"2024","journal-title":"Front Pharmacol"},{"key":"key20251111103947_b45-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"106202","DOI":"10.1016\/j.pestbp.2024.106202","article-title":"Emamectin benzoate and nanoplastics induce PANoptosis of common carp (Cyprinus carpio) gill through MAPK pathway","volume":"206","author":"Ju","year":"2024","journal-title":"Pestic Biochem Physiol"},{"key":"key20251111103947_b46-ol-30-6-15334","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.3390\/ijms23073847","article-title":"Metastasis and MAPK pathways","volume":"23","author":"Kciuk","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:39:55Z","timestamp":1762850395000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,10,14]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15334","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]}}}